Arachnoid Cysts Treatment Market Size

Arachnoid Cysts Treatment Market Size

Arachnoid Cysts Treatment Market size was valued at USD 1.3 Billion in 2023 growing at a CAGR of 5.7% between 2024 and 2032, driven by factors such as the rising incidence and prevalence of arachnoid cysts attributed to factors such as improved diagnostic techniques and an aging population, contribute to the expansion of the treatment market.

To get key market trends

  Download Free Sample

Moreover, advancement in diagnostic technologies, in neuroimaging techniques, such as MRI and CT scans, allow for more accurate and early detection of arachnoid cysts. This drives the demand for treatment options as patients are diagnosed at earlier stages. For instance, in June 2022, Siemens Healthineers introduces Symbia Pro.specta, a single photon emission computed tomography/computed tomography (SPECT/CT) system with CE mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging technologies. Symbia Pro.specta is an all-purpose system that can be customized to accommodate a wide range of clinical exams, patient types, and department settings.
 

Arachnoid cysts are the most common type of brain cyst. They are often congenital, or present at birth. Head injury or trauma can also result in a secondary arachnoid cyst. They affect people of all ages, but they arise in babies and children. Males are four times more likely to develop an arachnoid cyst than females. Treatment depends on where the cyst is and if it is growing or causing symptoms.